Clinical Case Reports (May 2021)
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
- Keiko Yamaoka,
- Shuichi Nagashima,
- Nobukazu Okada,
- Nagisa Sawayama,
- Shinsuke Saito,
- Manabu Takahashi,
- Kenta Okada,
- Kazuhiro Endo,
- Masaru Koizumi,
- Hideki Sasanuma,
- Ken Ebihara,
- Atsuko Kasajima,
- Noriyoshi Fukushima,
- Naohiro Sata,
- Shun Ishibashi
Affiliations
- Keiko Yamaoka
- Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan
- Shuichi Nagashima
- Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan
- Nobukazu Okada
- Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan
- Nagisa Sawayama
- Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan
- Shinsuke Saito
- Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan
- Manabu Takahashi
- Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan
- Kenta Okada
- Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan
- Kazuhiro Endo
- Department of Surgery Jichi Medical University Shimotsuke Japan
- Masaru Koizumi
- Department of Surgery Jichi Medical University Shimotsuke Japan
- Hideki Sasanuma
- Department of Surgery Jichi Medical University Shimotsuke Japan
- Ken Ebihara
- Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan
- Atsuko Kasajima
- Department of Pathology Tohoku University Graduate School of Medicine Sendai Japan
- Noriyoshi Fukushima
- Department of Pathology Jichi Medical University Shimotsuke Japan
- Naohiro Sata
- Department of Surgery Jichi Medical University Shimotsuke Japan
- Shun Ishibashi
- Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan
- DOI
- https://doi.org/10.1002/ccr3.4118
- Journal volume & issue
-
Vol. 9,
no. 5
pp. n/a – n/a
Abstract
Abstract Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR.
Keywords
